Is anavotx.com Safe? Security Analysis for Anavo Therapeutics
https://anavotx.comCheck if anavotx.com is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for anavotx.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Anavo Therapeutics is a pioneering biopharmaceutical company focused on drug discovery targeting phosphatases, a previously undruggable target class. Utilizing their proprietary IGNITE platform, they develop allosteric modulators for therapeutic programs in autoimmune diseases and cancer. The company is supported by reputable international investors and led by an experienced management team with strong scientific advisory backing. The website reflects a professional and consistent brand image with clear business focus and investor transparency. Technically, the website is built on the Squarespace platform with embedded Vimeo videos and uses modern web fonts and scripts. It is mobile optimized and performs moderately well, though accessibility features could be improved. Security posture is strong with HTTPS and HSTS enabled, and a cookie consent mechanism is in place, indicating GDPR awareness. However, the absence of a public WHOIS record, privacy policy, terms of service, and explicit contact information reduces transparency and trust. Overall, the site presents a credible and professional front for a biotech startup but would benefit from enhanced privacy and security disclosures, contact details, and domain registration transparency to improve trust and compliance.
Detected Technologies
7 urgent findings need attention
7 high
Keep anavotx.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
7 findings
35/100
GDPR Compliance
1 finding
95/100
NIS2 Compliance
8 findings
17/100
Email Security
4 findings
70/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Anavo Therapeutics occupies a niche market position as the first company systematically targeting phosphatases for drug discovery, addressing a significant unmet need in the biopharmaceutical industry. Their business model combines proprietary platform development with therapeutic program advancement and partnership support. The company targets investors, partners, and biotech professionals, leveraging a strong advisory board and blue-chip investors to establish credibility. Growth indicators include recent funding rounds and a focus on autoimmune and oncology indications. The partnership ecosystem includes major venture capital and pharmaceutical investors, enhancing strategic positioning. The company’s operations appear focused on innovation and pipeline development rather than direct sales or e-commerce. The website content and structure support investor relations and recruitment efforts, indicating a growth and talent acquisition phase.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a mature security posture with enforced HTTPS and HSTS headers, reducing risks of man-in-the-middle attacks. The presence of a cookie consent banner aligns with GDPR requirements, though no explicit privacy policy or terms of service documents were found, representing a compliance gap. No security.txt or vulnerability disclosure information is published, limiting transparency for security researchers. No exposed sensitive data or vulnerable libraries were detected in the site scripts. The absence of contact information for incident response or security inquiries is a weakness. Overall, the security posture is good but could be improved by publishing comprehensive policies and contact channels.
Strategic Recommendations
Priority Actions for Security Improvement
Publish a comprehensive privacy policy and terms of service to improve legal compliance and user trust.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Anavo Therapeutics
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. They develop first-in-class therapeutic programs targeting phosphatases using their IGNITE platform, focusing on autoimmune diseases and cancer. Backed by blue-chip investors, they aim to unlock the therapeutic potential of phosphatase-targeted allosteric modulators.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- HSTS enabled
- Cookie consent banner implemented
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is professionally designed and content-rich for a biotech startup.
Get this report delivered to your inbox
Receive a summary of the anavotx.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Strict-Transport-Security configuration
LOWCurrent value: "max-age=15552000"
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete anavotx.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 81 days
Mixed Content Detected
MEDIUM2 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does anavotx.com compare?
See how anavotx.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the anavotx.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the anavotx.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about anavotx.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published